WO2004019987A1 - 貼付剤 - Google Patents
貼付剤 Download PDFInfo
- Publication number
- WO2004019987A1 WO2004019987A1 PCT/JP2003/010091 JP0310091W WO2004019987A1 WO 2004019987 A1 WO2004019987 A1 WO 2004019987A1 JP 0310091 W JP0310091 W JP 0310091W WO 2004019987 A1 WO2004019987 A1 WO 2004019987A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymer
- rubber
- acid
- patch
- copolymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/526,065 US20060110433A1 (en) | 2002-08-28 | 2003-08-07 | Adhesive patch |
AU2003254874A AU2003254874A1 (en) | 2002-08-28 | 2003-08-07 | Adhesive patch |
EP03791199A EP1541176A4 (en) | 2002-08-28 | 2003-08-07 | ADHESIVE STAMP |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002249417A JP4213432B2 (ja) | 2002-08-28 | 2002-08-28 | 貼付剤 |
JP2002-249417 | 2002-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004019987A1 true WO2004019987A1 (ja) | 2004-03-11 |
Family
ID=31972576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/010091 WO2004019987A1 (ja) | 2002-08-28 | 2003-08-07 | 貼付剤 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20060110433A1 (ja) |
EP (1) | EP1541176A4 (ja) |
JP (1) | JP4213432B2 (ja) |
KR (1) | KR100971643B1 (ja) |
CN (1) | CN100411687C (ja) |
AU (1) | AU2003254874A1 (ja) |
WO (1) | WO2004019987A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7890950B1 (en) | 2005-05-31 | 2011-02-15 | Adobe Systems Incorporated | Software uninstallation that integrates transfer activation |
US8173155B2 (en) | 2004-06-01 | 2012-05-08 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4354678B2 (ja) * | 2002-08-28 | 2009-10-28 | 久光製薬株式会社 | 貼付剤 |
JP4792193B2 (ja) * | 2002-08-28 | 2011-10-12 | 久光製薬株式会社 | 貼付剤 |
TW200514582A (en) * | 2003-10-31 | 2005-05-01 | Hisamitsu Pharmaceutical Co | Transdermal preparation and method for reducing side effect in pergolide therapy |
ES2395290T3 (es) * | 2004-04-13 | 2013-02-11 | Nipro Patch Co., Ltd. | Adhesivo piezosensible reticulable para la piel |
WO2005115355A1 (ja) * | 2004-05-28 | 2005-12-08 | Hisamitsu Pharmaceutical Co., Inc. | 貼付製剤 |
DE602006020738D1 (de) | 2005-08-01 | 2011-04-28 | Hisamitsu Pharmaceutical Co | Adjuvans oder pharmazeutische zubereitung zur transdermalen oder transmukosalen verabreichung |
EP2078524B1 (en) * | 2006-10-27 | 2016-08-31 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive skin patch |
US20100047327A1 (en) * | 2007-01-31 | 2010-02-25 | Tetsuji Kuwahara | Adjuvant for Transdermal or Transmucosal Administration and Pharmaceutical Preparation Containing the Same |
DE102008013701A1 (de) * | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit stabilisierter Membran |
US20090297590A1 (en) * | 2008-05-30 | 2009-12-03 | Masahiro Yamaji | Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease |
EP2476414B1 (en) * | 2009-09-07 | 2015-03-04 | NIPRO Patch Co., Ltd. | Transdermally absorbable preparation |
JP6114401B2 (ja) | 2013-10-31 | 2017-04-12 | 久光製薬株式会社 | アジュバント組成物、これを含むアジュバント製剤、及びキット |
BR112017013255B1 (pt) * | 2014-12-22 | 2022-08-09 | Hisamitsu Pharmaceutical Co., Inc | Cataplasma |
KR102633741B1 (ko) * | 2021-08-05 | 2024-02-06 | 주식회사 영우 | 부착성과 흡수성이 우수한 드레싱재 |
CN113476459A (zh) * | 2021-08-16 | 2021-10-08 | 浙江鼎泰药业股份有限公司 | 一种高活性缓释止痛贴及其制备工艺 |
KR102646740B1 (ko) * | 2021-10-15 | 2024-03-13 | 주식회사 영우 | 수용성 점착 드레싱재 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04368323A (ja) * | 1991-06-12 | 1992-12-21 | Sekisui Chem Co Ltd | 貼付剤 |
WO1996040139A1 (en) * | 1995-06-07 | 1996-12-19 | Alza Corporation | Novel formulations for transdermal delivery of pergolide |
JPH09315957A (ja) * | 1996-05-28 | 1997-12-09 | Hisamitsu Pharmaceut Co Inc | 経皮治療用装置 |
EP0993829A1 (en) * | 1996-12-11 | 2000-04-19 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal preparation containing serotonin receptor antagonist |
WO2002038139A1 (fr) * | 2000-11-07 | 2002-05-16 | Hisamitsu Pharmaceutical Co., Inc. | Preparation pharmaceutique du type a absorption percutanee |
JP2002515424A (ja) * | 1998-05-15 | 2002-05-28 | シュバルツ ファルマ アクチェンゲゼルシャフト | ペルゴリド含有経皮吸収治療システム(tts) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5717062A (en) * | 1995-06-07 | 1998-02-10 | Beth Israel Hospital Association | Cyclic analogs of PTH and PTHrP |
US7988991B2 (en) * | 2001-03-07 | 2011-08-02 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
JP4404251B2 (ja) * | 2001-08-10 | 2010-01-27 | 久光製薬株式会社 | 経皮吸収型製剤 |
CN1541112A (zh) * | 2001-08-10 | 2004-10-27 | �ù���ҩ��ʽ���� | 经皮吸收制剂 |
JP4792193B2 (ja) * | 2002-08-28 | 2011-10-12 | 久光製薬株式会社 | 貼付剤 |
-
2002
- 2002-08-28 JP JP2002249417A patent/JP4213432B2/ja not_active Expired - Lifetime
-
2003
- 2003-08-07 WO PCT/JP2003/010091 patent/WO2004019987A1/ja active Application Filing
- 2003-08-07 EP EP03791199A patent/EP1541176A4/en not_active Withdrawn
- 2003-08-07 US US10/526,065 patent/US20060110433A1/en not_active Abandoned
- 2003-08-07 KR KR1020057002545A patent/KR100971643B1/ko not_active IP Right Cessation
- 2003-08-07 CN CNB038206846A patent/CN100411687C/zh not_active Expired - Fee Related
- 2003-08-07 AU AU2003254874A patent/AU2003254874A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04368323A (ja) * | 1991-06-12 | 1992-12-21 | Sekisui Chem Co Ltd | 貼付剤 |
WO1996040139A1 (en) * | 1995-06-07 | 1996-12-19 | Alza Corporation | Novel formulations for transdermal delivery of pergolide |
JPH09315957A (ja) * | 1996-05-28 | 1997-12-09 | Hisamitsu Pharmaceut Co Inc | 経皮治療用装置 |
EP0993829A1 (en) * | 1996-12-11 | 2000-04-19 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal preparation containing serotonin receptor antagonist |
JP2002515424A (ja) * | 1998-05-15 | 2002-05-28 | シュバルツ ファルマ アクチェンゲゼルシャフト | ペルゴリド含有経皮吸収治療システム(tts) |
WO2002038139A1 (fr) * | 2000-11-07 | 2002-05-16 | Hisamitsu Pharmaceutical Co., Inc. | Preparation pharmaceutique du type a absorption percutanee |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8173155B2 (en) | 2004-06-01 | 2012-05-08 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
US7890950B1 (en) | 2005-05-31 | 2011-02-15 | Adobe Systems Incorporated | Software uninstallation that integrates transfer activation |
Also Published As
Publication number | Publication date |
---|---|
EP1541176A1 (en) | 2005-06-15 |
CN100411687C (zh) | 2008-08-20 |
CN1678352A (zh) | 2005-10-05 |
KR20050056985A (ko) | 2005-06-16 |
EP1541176A4 (en) | 2010-11-24 |
KR100971643B1 (ko) | 2010-07-22 |
JP2004083520A (ja) | 2004-03-18 |
US20060110433A1 (en) | 2006-05-25 |
JP4213432B2 (ja) | 2009-01-21 |
AU2003254874A1 (en) | 2004-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4792193B2 (ja) | 貼付剤 | |
KR100846642B1 (ko) | 첩부제 | |
US6117447A (en) | Percutaneous absorption type preparation | |
WO2004019987A1 (ja) | 貼付剤 | |
KR101392064B1 (ko) | 첩부제 및 그 제조 방법 | |
US20040028724A1 (en) | Pharmaceutical preparation of percutaneous absorption type | |
EP2078524B1 (en) | Adhesive skin patch | |
WO2006095820A1 (ja) | 粘着剤及び貼付剤 | |
WO2006080199A1 (ja) | 貼付剤 | |
JP4354678B2 (ja) | 貼付剤 | |
WO2006048939A1 (ja) | 非ステロイド消炎鎮痛薬を含有する非水系経皮吸収製剤 | |
WO2003013611A1 (fr) | Preparations a absorption par voie cutanee | |
JP4404251B2 (ja) | 経皮吸収型製剤 | |
TWI805535B (zh) | 含有利多卡因之貼附劑 | |
JP7253127B2 (ja) | フェンタニル含有貼付剤 | |
TW202227053A (zh) | 抑制阿申那平(asenapine)之分解之方法 | |
TW202227054A (zh) | 含有阿申那平(asenapine)之貼附劑 | |
WO2018038022A1 (ja) | 貼付剤 | |
JP2004224741A (ja) | ツロブテロール経皮吸収型製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1020057002545 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 20038206846 Country of ref document: CN |
|
REEP | Request for entry into the european phase |
Ref document number: 2003791199 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003791199 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006110433 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10526065 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2003791199 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057002545 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10526065 Country of ref document: US |